Sort
46,585 grants matching “heart failure”
Epoxyeicosatrienoic acids, diabetes, and cardiovascular disease
$701,774Rozenn Lemaitre · University Of Washington · R01 · FY2016 · HL
Handoffs and Transitions in Critical Care - Understanding Scalability
$701,730Meghan Brooks Lane-Fall · University Of Pennsylvania · R01 · FY2022 · HL
4D Multimodal Image-Based Modeling for Bicuspid Aortic Valve Repair Surgery
$701,690Alison Marie Pouch · University Of Pennsylvania · R01 · FY2023 · HL
Genetic Determinants of Premature Vascular Dysfunction in Families
$701,682Dhananjay Madhukar Vaidya · Johns Hopkins University · R01 · FY2010 · HL
Multiscale spatiotemporal modeling of cardiac mitochondria
$701,611William Jonathan Lederer · University Of Maryland Baltimore · U01 · FY2016 · HL
Genetic Markers and gene expression in Kawasaki Disease
$701,575Jane C Burns · University Of California, San Diego · R01 · FY2007 · HL
CoPARC: Colorado Pulmonary Alcohol Research Collaborative
$701,519Ellen L Burnham · University Of Colorado Denver · R24 · FY2020 · AA
Resistin regulates NLRP3 inflammasome in pulmonary hypertension
$701,467Roger A Johns · Johns Hopkins University · R01 · FY2023 · HL
Monitoring Community Trends in Heart Failure
$701,308Univ Of Massachusetts Med Sch Worcester · R37 · FY2004 · HL
Personalized Risk Prediction to Reduce Cardiovascular Disease in Childhood Cancer Survivors
$701,204Rebecca Maureen Howell · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Factors Associated with Response to Cardiac Resynchronization Therapy in Heart Failure Patients with Non-LBBB ECG Pattern
$701,196Valentina Kutyifa Valentina Kutyifa Valentina Kutyifa · University Of Rochester · R01 · FY2022 · HL
Chip phosphorylation stimulates the degradation of mutant transthyretin to attenuate cardiac amyloidosis
$701,186Mark John Ranek · Johns Hopkins University · R01 · FY2024 · HL
Genetic Markers and gene expression in Kawasaki Disease
$701,156Jane C Burns · University Of California, San Diego · R01 · FY2008 · HL
Cardiovascular Risk of Antiretroviral Therapy Drugs in HIV
$701,122Jasimuddin Ahamed · Oklahoma Medical Research Foundation · R01 · FY2023 · HL
Targeting cardiovascular events to improve patient outcomes after sepsis
$701,112Allan J. Walkey · Boston University Medical Campus · R01 · FY2019 · HL
Cardiac Magnetic Resonance for Tissue Characterization Based Risk Stratification of Cardiopulmonary Symptoms, Effort Tolerance, and Prognosis Among COVID-19 Survivors
$701,089Jiwon Kim · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · HL
Characterization of Coagulation Factor-platelet Interactions: Role of FXI
$701,086Owen J McCarty · Oregon Health & Science University · R01 · FY2022 · HL
Effects of chronic marijuana use on endothelial function
$701,028Matthew Lawrence Springer · University Of California, San Francisco · R01 · FY2023 · DA
Feeding Behaviors & Energy Cost in Infants with CHD
$701,026Barbara S Medoff-Cooper · Children'S Hosp Of Philadelphia · R01 · FY2006 · NR
Mitochondrial Function and Multiomics in Aging-related Disease: Identifying Novel Biomarkers and Causal Relationships
$700,999Dan E Arking · Johns Hopkins University · R01 · FY2024 · AG
MItochondrial Dysfunction in Cardiac Hypertrophy and Failure
$700,977Brian O'Rourke · Johns Hopkins University · R01 · FY2010 · HL
Cardiotoxicity in Total Joint Arthroplasty
$700,927Hilal Maradit Kremers · Mayo Clinic Rochester · R01 · FY2022 · HL
Cardiotoxicity in Total Joint Arthroplasty
$700,927Hilal Maradit Kremers · Mayo Clinic Rochester · R01 · FY2020 · HL
Cardiotoxicity in Total Joint Arthroplasty
$700,927Hilal Maradit Kremers · Mayo Clinic Rochester · R01 · FY2019 · HL
Cardiotoxicity in Total Joint Arthroplasty
$700,927Hilal Maradit Kremers · Mayo Clinic Rochester · R01 · FY2021 · HL